Umckamin solution, an effective therapeutic option in acute and exacerbating bronchitis
Published: 2008-01-14 06:58:00
Updated: 2008-01-14 06:58:00
The efficacy and tolerability of Umckamin (Pelargonium sidoides), which was launched by Yuyu Pharm last November, has been demonstrated in a recent clinical trial of 103 patients suffering from acute bronchitis or acute exacerbation of chronic bronchitis.
The clinical results showed that Umcka...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
